Skip to main content

Want a detailed portfolio tracker?

Septerna (SEPN) P/E (2024 - 2026)

Septerna (SEPN) P/E from Dec 31, 2024 to Jul 20, 2026. The TTM Septerna (SEPN) P/E is -39.94. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Septerna (SEPN)

YearP/EChange
2026-39.94+57.21%
2025-25.41-48.37%
2024-49.22N/A

Comparison Septerna (SEPN) P/E with competitors

Septerna (SEPN) P/E is -39.94.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.19%
FGENFibroGen Inc0.24-100.60%
CHRSCoherus Biosciences Inc0.85-102.12%
FBIOFortress Biotech Inc0.95-102.38%
ORMPOramed Pharmaceuticals Inc1.50-103.76%
AGENAgenus Inc3.01-107.53%
INVAInnoviva Inc3.15-107.90%
VXRTVaxart Inc3.55-108.89%
CRMDCorMedix Inc3.63-109.08%
CVACCureVac N.V.4.45-111.13%
GLPGGalapagos NV4.86-112.16%
SRPTSarepta Therapeutics Inc4.88-112.22%
ABEOAbeona Therapeutics Inc5.39-113.49%
ABUSArbutus Biopharma Corp5.60-114.01%
ZVRAZevra Therapeutics Inc5.89-114.74%
SPROSpero Therapeutics Inc6.23-115.59%
CGENCompugen Ltd6.31-115.81%
RIGLRigel Pharmaceuticals6.87-117.20%
SLXNSilexion Therapeutics Corp7.30-118.27%
OMEROmeros Corporation9.26-123.18%
AUPHAurinia Pharmaceuticals Inc9.58-124.00%
PLXProtalix BioTherapeutics Inc10.89-127.26%
ACADAcadia Pharmaceuticals Inc11.73-129.36%
TBPHTheravance Biopharma Inc12.26-130.70%
ADMAAdma Biologics Inc12.42-131.09%
HRMYHarmony Biosciences Holdings Inc13.82-134.60%
SABSSAB Biotherapeutics Inc14.14-135.39%
NAGENiagen Bioscience Inc14.82-137.10%
INCYIncyte Corp15.82-139.61%
REGNRegeneron Pharmaceuticals Inc15.86-139.70%
PBYIPuma Biotechnology Inc17.32-143.35%
CPRXCatalyst Pharmaceuticals Inc17.44-143.66%
EXELExelixis Inc17.54-143.91%
TGTXTG Therapeutics Inc18.97-147.48%
MDXGMimedx Group Inc20.55-151.45%
XOMAXOMA Royalty Corp22.87-157.27%
ARGXArgen X SE24.30-160.83%
CTMXCytomX Therapeutics Inc24.82-162.14%
XOMAOXOMA Royalty Corp25.34-163.45%
HALOHalozyme Therapeutics Inc25.62-164.15%
XOMAPXOMA Royalty Corp25.67-164.26%
VRTXVertex Pharmaceuticals Inc27.99-170.08%
RPRXRoyalty Pharma plc - Class A28.69-171.82%
SLNOSoleno Therapeutics Inc29.02-172.64%
ASNDAscendis Pharma A/S30.09-175.32%
LGNDLigand Pharmaceuticals Inc - Class B37.91-194.91%
APLSApellis Pharmaceuticals Inc39.02-197.69%
BMRNBiomarin Pharmaceutical Inc42.21-205.68%
KRYSKrystal Biotech Inc45.34-213.52%
ONCBeiGene Ltd69.54-274.09%
PHARPharming Group N.V.75.03-287.83%
TECHBio-Techne Corp101.96-355.25%
VCELVericel Corp109.92-375.19%
ALNYAlnylam Pharmaceuticals Inc117.96-395.33%
GMABGenmab140.29-451.22%
TLXTelix Pharmaceuticals Ltd162.15-505.95%
CORTCorcept Therapeutics Inc212.86-632.89%